Research
Our faculty work on clinical trials related to inflammatory bowel diseases, eosinophilic esophagitis, gastroparesis, alcoholic and non-alcoholic hepatitis, NASH, and other gastrointestinal and hepatology illnesses.
The Alcohol Liver Study Unit is comprised of a large team of basic scientists conducting ongoing research investigating:
- How alcohol consumption affects protein degradation in the liver and the brain.
- Ethanol metabolism on cellular replication.
- Ethanol as it relates to altered protein trafficking and the pathogenesis of alcoholic liver injury.
- The role of iron as a secondary risk factor in liver diseases, including oxidative stress induced by agents such as alcohol or hepatitis C viral proteins is one of the primary underlying mechanisms of iron overload.
Understanding these processes may help researchers develop novel diagnostic markers and therapeutic strategies.
Faculty Research

Alexander Hewlett, DO
Outcomes in Gastroparesis, Pharmacological studies in Eosinophilic esophagitis, Patient outcomes in Eosinophilic esophagitis.

Peter J. Mannon, MD, MPH
Specimen and Tissue Banking for the Study of Inflammatory Bowel Diseases

Wuttiporn (Shane) Manatsathit, MD
Non-alcoholic fatty liver disease (NAFLD), Non-invasive liver fibrosis measurements, Clinical care of liver transplant candidates and post-transplant care.
Research Support
Carol Carney
Clinical Research Projects Manager
Office: 402-559-4367
Navpreet Dhillon
Clinical Research Coordinator
Office: 402-836-9594
Deanna Gibson
Research Nurse Coordinator
Office: 402-559-8256